BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23768458)

  • 1. Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial).
    Vemulapalli S; Zhou Y; Gutberlet M; Kumar AS; Mills JS; Blaxill J; Smalling R; Ohman EM; Patel MR
    Am J Cardiol; 2013 Oct; 112(7):911-7. PubMed ID: 23768458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.
    Patel MR; Smalling RW; Thiele H; Barnhart HX; Zhou Y; Chandra P; Chew D; Cohen M; French J; Perera D; Ohman EM
    JAMA; 2011 Sep; 306(12):1329-37. PubMed ID: 21878431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
    Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction).
    Guerchicoff A; Brener SJ; Maehara A; Witzenbichler B; Fahy M; Xu K; Gersh BJ; Mehran R; Gibson CM; Stone GW
    JACC Cardiovasc Interv; 2014 Jul; 7(7):733-40. PubMed ID: 25060015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).
    Shah R; Clare RM; Chiswell K; Jones WS; Kumar AS; Thiele H; Smalling RW; Chandra P; Cohen M; Perera D; Chew DP; French JK; Blaxill J; Ohman EM; Patel MR
    Am J Med; 2016 Dec; 129(12):1307-1315. PubMed ID: 27542611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).
    Palmerini T; Brener SJ; Genereux P; Maehara A; Della Riva D; Mariani A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Fahy M; Xu K; Gibson CM; Stone GW
    Am J Cardiol; 2013 Dec; 112(12):1860-6. PubMed ID: 24063843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Yoon SJ; Ko YG; Kim JS; Moon JY; Kim YJ; Park S; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Coron Artery Dis; 2009 Nov; 20(7):440-5. PubMed ID: 19730371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials.
    Stone GW; Dixon SR; Grines CL; Cox DA; Webb JG; Brodie BR; Griffin JJ; Martin JL; Fahy M; Mehran R; Miller TD; Gibbons RJ; O'Neill WW
    Am J Cardiol; 2007 Nov; 100(9):1370-5. PubMed ID: 17950792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
    Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.
    van de Hoef TP; Bax M; Meuwissen M; Damman P; Delewi R; de Winter RJ; Koch KT; Schotborgh C; Henriques JP; Tijssen JG; Piek JJ
    Circ Cardiovasc Interv; 2013 Jun; 6(3):207-15. PubMed ID: 23735476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.
    Kohl LP; Leimberger JD; Chiswell K; Jones WS; Thiele H; Smalling RW; Chandra P; Cohen M; Perera D; Chew DP; French JK; Blaxil J; Kumar AS; Ohman EM; Patel MR
    Am Heart J; 2016 Apr; 174():7-13. PubMed ID: 26995364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial.
    Jones WS; Clare RM; Chiswell K; Perera D; French JK; Kumar AS; Blaxill J; Pijls N; Mills J; Ohman EM; Patel MR
    Clin Cardiol; 2015 Jan; 38(1):25-31. PubMed ID: 25488040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial).
    Marquis-Gravel G; Thiele H; Jones WS; Smalling RW; Cohen M; Perera D; Pijls N; Fanaroff A; Brucker A; Chiswell K; Patel MR; Ohman EM
    Am J Cardiol; 2019 Apr; 123(7):1026-1034. PubMed ID: 30642606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevoflurane in acute myocardial infarction: a pilot randomized study.
    Lavi S; Bainbridge D; D'Alfonso S; Diamantouros P; Syed J; Jablonsky G; Lavi R
    Am Heart J; 2014 Nov; 168(5):776-83. PubMed ID: 25440807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial).
    Gennaro G; Brener SJ; Redfors B; Kirtane AJ; Généreux P; Maehara A; Neunteufl T; Metzger DC; Mehran R; Gibson CM; Stone GW
    Am J Cardiol; 2016 Oct; 118(8):1097-1104. PubMed ID: 27553094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
    Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
    Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.